GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ARDEA BIOSCIENCES (RDEA) [hlAlert]

Ardea Biosciences, Inc. is a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency
virus (HIV), cancer and inflammatory diseases, including gout. The Company's portfolio of product candidates include RDEA806 and 2nd generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV indication; RDEA594 for gout; RDEA119 for cancer; RDEA119 for inflammation, and mitogen-activated ERK kinase (MEK) inhibitor for cancer/inflammation.
.
( Total: 18 Current Stock Recommendations )
ARDEA BIOSCIENCES   (18)
Hold Buy 94%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
Heron Therapeutics ...   (7)
Buy 100%
CELSION CORP   (5)
Buy 100%
China Biologic ...   (3)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (4)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Oncogenex ...   (8)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Period:  

RankMemberRatingSymbolYTD Gains
1 Oppenheimer Buy RDEA up  263.18 %
2 Leerink Swann Buy RDEA up  199.25 %
3 Merriman Curhan Ford Buy RDEA up  129.59 %
4 Piper Jaffray Buy RDEA up  120.71 %
5 Cowen & Co Buy RDEA up  120.71 %
6 Soleil Buy RDEA up  117.71 %
7 Jefferies & Co Buy RDEA up  111.65 %
8 Roth Capital Buy RDEA up  111.23 %
9 Collins Stewart Buy RDEA up  94.87 %
10 Mehta Partners Buy RDEA up  59.32 %
11 UBS Buy RDEA up  55.52 %
12 MLV & Co Buy RDEA up  53.80 %
13 Jefferies Buy RDEA up  41.66 %
14 JMP Securities Buy RDEA up  41.66 %
15 Canaccord Genuity Buy RDEA up  37.81 %
16 Boenning & Scattergood Buy RDEA up  29.13 %
17 Stifel Nicolaus Buy RDEA up  25.38 %
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy